Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
1 woman dead, 4 critical after childbirth Bengal; ‘expired saline’, claim kin
A 22-year-old woman died and four others are critically ill after C-sections at Midnapore Medical College Hospital; their families blame expired Ringer’s lactate IV solution. […]
Can Root break Tendulkar’s record? Alastair Cook gives his verdict
Joe Root has the potential to surpass Sachin Tendulkar’s record as the highest run scorer in Test cricket, says former England captain Alastair Cook. Root […]
India’s Got Latent row: SC grants interim protection to Ranveer Allahbadia from arrest
The Supreme Court criticized Ranveer Allahbadia for his offensive remarks on social media, emphasizing that free speech does not permit such comments. He and others […]